- register - Lost Password ? - Inbox

logo

SEARCH:
Latest Feed Items (CANADA - USA) - NSD - (CORT) Corcept Therapeutics Inc.
Shares O/S 115,235,013Market Cap $2,142,218,892
Tuesday, May 11 2010 - 10:29am

Corcept takes bigger 1Q loss on testing costs (AP)

Drug developer Corcept Therapeutics Inc. reported a larger first-quarter loss Tuesday as it spent more money to test its drug candidate Corlux and prepares to launch the product if it gains regulatory approval.


Read more...

Copyright TradingChief.Com 2005-2018